Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Bolt Biotherapeutics (BOLT) Non Operating Income (2020 - 2025)

Bolt Biotherapeutics (BOLT) has disclosed Non Operating Income for 6 consecutive years, with $454000.0 as the latest value for Q4 2025.

  • Quarterly Non Operating Income fell 53.67% to $454000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $2.7 million through Dec 2025, down 72.44% year-over-year, with the annual reading at $2.7 million for FY2025, 72.44% down from the prior year.
  • Non Operating Income hit $454000.0 in Q4 2025 for Bolt Biotherapeutics, down from $559000.0 in the prior quarter.
  • In the past five years, Non Operating Income ranged from a high of $6.3 million in Q1 2024 to a low of -$6.0 million in Q1 2021.
  • Historically, Non Operating Income has averaged $804300.0 across 5 years, with a median of $814500.0 in 2024.
  • Biggest five-year swings in Non Operating Income: tumbled 5482.14% in 2021 and later skyrocketed 1371.95% in 2022.
  • Year by year, Non Operating Income stood at -$82000.0 in 2021, then surged by 1371.95% to $1.0 million in 2022, then soared by 78.62% to $1.9 million in 2023, then plummeted by 47.4% to $980000.0 in 2024, then plummeted by 53.67% to $454000.0 in 2025.
  • Business Quant data shows Non Operating Income for BOLT at $454000.0 in Q4 2025, $559000.0 in Q3 2025, and $649000.0 in Q2 2025.